Kristen Whitney, DO, FAAD, dermatologist at Allegheny Health Network, highlighted recent breakthroughs in treating alopecia areata, focusing on the effectiveness of Janus kinase inhibitors and the ongoing challenges related to insurance coverage and patient access.
Alopecia Areata Risk in Patients With IBD Tied to Anti-TNF Use
Pediatric Alopecia Areata Risks and Disparities Vary by Race and Ethnicity
Alopecia Areata Shares Inflammatory Link With Asthma
Upadacitinib May Induce Alopecia Areata in Patients With AD
Alopecia Areata Treatment Advancements and Emerging Technology
New Genetic Insights Into Alopecia Areata
Alopecia Areata Linked With Hypothyroidism
Insights on the Future Direction of AA Treatment
Advancing Research on Alopecia Areata Treatment and Epidemiology
New HRQOL Measurements Necessary for Patients With AA
Tailoring Treatment for Alopecia Areata
Long-Term Efficacy of Baricitinib for Severe Alopecia Areata
Alopecia Areata Linked to Autoimmune, Psychiatric Risks
Alopecia Areata Research Increases Over the Last 2 Decades
Alopecia Treatment With Autologous Fat Grafting Shows Promise
Expert Insights on Deuruxolitinib for Alopecia Areata
Research Explores Novel Insights on Pediatric Hair Loss
High Treatment Costs Burden Patients With Alopecia Areata Despite Limited Treatment Efficacy
FDA Approves Deuruxolitinib for Alopecia Areata
Exploring Comorbidities, Dupilumab Treatment in Pediatric Alopecia Areata
Diagnosing and Managing Scarring Alopecia in Adolescents
New Study Suggests Alopecia After COVID-19 Vaccine Rare but Possible
Expert Consensus Offers Guidance for Treating Androgenetic Alopecia
Nail Changes in Alopecia Areata: Review of Manifestations, Diagnosis, Management Strategies
Survey Shows Suboptimal Comfort in Treating Hair Among Patients With SOC
Lasers Offer New Options for Hair Loss Treatment in Alopecia Management
Alopecia Areata Hair Breakage Linked to Cysteine Deficiency
Exploring the Potential of Thyroid Receptor β for Treating Androgenetic Alopecia
Unveiling Treatment Options for Alopecia Areata
Ritlecitinib Effective For Patients With Alopecia Areata, Improves Hair Regrowth
Benefits of JAK Inhibitors Compared With Existing Therapies for AA Treatment
Scalp Cooling Therapy Effective in Reducing Chemotherapy-Induced Alopecia
History of Oral Contraceptive Use, Gene Variant May Increase Risk of FFA
Patients With AGA Treated With PRP Display Hair Regrowth, Potential Microbiome Rebalance
Primary Cicatricial Alopecia Connected to Increased Risk of Endocrine, Metabolic Diseases